Circulating Biomarkers to Identify Thyroid Cancer

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

October 31, 2019

Study Completion Date

September 30, 2020

Conditions
Thyroid CancerThyroid Cancer, PapillaryBenign Thyroid Tumor
Interventions
OTHER

Identification group

papillary thyroid cancers (n=10) and benign thyroid tumors (n=10)

OTHER

Validation group

papillary thyroid cancers (n=45) and benign thyroid tumors (n=35)

Trial Locations (1)

83301

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT04594720 - Circulating Biomarkers to Identify Thyroid Cancer | Biotech Hunter | Biotech Hunter